Kyle Ekman's questions to Evolent Health Inc (EVH) leadership • Q3 2024
Question
Kyle Ekman of JPMorgan Chase & Co. asked about the financial contribution and timing of new partnerships and sought details on the accounts receivable collection slowdown.
Answer
John Johnson detailed that the six new agreements represent approximately $200 million in annualized revenue, with all expected to go live in 2025. Regarding accounts receivable, he attributed the slowdown to a couple of specific partners, expressed no concern over ultimate collectibility, and noted the new financing was a proactive measure for both collections and upcoming debt maturities.